Publications by authors named "Andre Abitbol"

Claim this Profile
L
Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer.
Lisa A Kachnic, Kathryn A Winter, Robert J Myerson, Michael D Goodyear, Andre A Abitbol

Int J Radiat Oncol Biol Phys· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Radiation Therapy-Related Gastrointestinal Toxicity From Anal Cancer Dose-Painted Intensity Modulated Radiation Therapy: Secondary Analysis of NRG Oncology RTOG 0529.
Jeffrey R Olsen, Jennifer Moughan, Robert Myerson, Andre Abitbol, Desiree E Doncals

Int J Radiat Oncol Biol Phys· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerated partial breast irradiation is safe and effective using intensity-modulated radiation therapy in selected early-stage breast cancer.
Alan A Lewin, Robert Derhagopian, Kunal Saigal, Joseph E Panoff, Andre Abitbol

Int J Radiat Oncol Biol Phys· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation technique influence on percutaneous endoscopic gastrostomy tube dependence: Comparison between two radiation schemes.
Georges F Hatoum, Andre Abitbol, Inas Elattar, Alan Lewin, Michael Troner

Head Neck· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation--CyberKnife.
William T Brown, Xiaodong Wu, Beatriz Amendola, Mark Perman, Hoke Han, Andre Abitbol

Cancer J· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete hypopharyngeal obstruction by mucosal adhesions: a complication of intensive chemoradiation for advanced head and neck cancer.
Elizabeth J Franzmann, Donna S Lundy, Andre A Abitbol, W Jarrard Goodwin

Head Neck· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of tolerance and efficacy of hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (taxol) and amifostine (ethyol) in head and neck squamous cell carcinomas: A-3 protocol.
Andre Abitbol, May Abdel-Wahab, Mark Harvey, Alan Lewin, Michael Troner

Am J Clin Oncol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality-of-life assessment after hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in inoperable and/or unresectable head and neck squamous cell carcinoma.
May Abdel-Wahab, Andre Abitbol, Alan Lewin, Michael Troner, Kara Hamilton

Am J Clin Oncol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol.
Andre Abitbol, May Abdel-Wahab, Alan Lewin, Michael Troner, Maria Amelia Rodrigues

Int J Radiat Oncol Biol Phys· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis